October 31, 2019

Patents, when properly granted, can be vital to our economy. But in recent years patent abuse has become more common, resulting in many low-quality patents and patents whose only value is to block competition on earlier inventions entering the public domain. Companies...

October 30, 2019

Earlier this week, the House of Representatives, in an encouraging step for consumers, unanimously passed a bipartisan bill to lower drug prices by regulating pharmacy benefit managers (PBMs) and bringing more transparency to the PBM market.

The Public Disclosure of Dru...

October 21, 2019

Last week on Thursday, October 17th the House Energy and Commerce Committee approved Speaker Nancy Pelosi's broad bill to reduce prescription drug costs, and added a couple of amendments that strengthened the bill. While the legislation has to be approved by other comm...

October 14, 2019

Senators, prescription drug experts, and other advocates are expressing more concerns about AbbVie's $63 billion acquisition of Allergan and its impacts on competition and consumers. Both drug companies are notorious for their anticompetitive behavior and attempts to p...

October 10, 2019

Three weeks ago, Consumer Action held its annual conference in Chicago, where over a hundred consumer advocates heard about various consumer issues. Rising prescription drug prices are a huge problem, and a great many of the advocates said reducing them was a top prior...

October 3, 2019

Over forty three million Americans are enrolled in Medicare, the federal health care programs for seniors that has a substantial prescription drug benefit. But these beneficiaries are increasingly paying higher out of pocket costs at the pharmacy counter. Why? Because...

Please reload

Featured Posts

United States-Mexico-Canada Agreement (USMCA)

October 5, 2018

1/4
Please reload

Recent Posts
Please reload

Archive